Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × niraparib × 1 year × Clear all

Sponsor

Conditions

Ovarian Neoplasms 23 Prostatic Neoplasms 10 Breast Neoplasms 10 Fallopian Tube Neoplasms 9 Neoplasms 7 Neoplasm Metastasis 7 Pancreatic Neoplasms 6 Endometrial Neoplasms 5 Glioblastoma 4 Triple Negative Breast Neoplasms 3 Lung Neoplasms 3 Glioma 3 Small Cell Lung Carcinoma 2 Recurrence 2 Prostatic Neoplasms, Castration-Resistant 2 Head and Neck Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Brain Neoplasms 2 Biliary Tract Neoplasms 2 Advanced Solid Tumor 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Unilateral Breast Neoplasms 1 Sarcoma 1 SCLC,Extensive Stage 1 Rectal Neoplasms 1 Prostate Carcinoma Metastatic to the Bone 1 Prostate Adenocarcinoma 1

Interventions

pembrolizumab 119 Cisplatin 70 Cetuximab 52 Carboplatin 46 Nivolumab 39 Paclitaxel 38 Docetaxel 33 Radiotherapy 32 Radiotherapy, Intensity-Modulated 23 Fluorouracil 19 Magnetic Resonance Spectroscopy 18 Specimen Handling 16 Taxes 11 durvalumab 10 cemiplimab 10 Radiation 10 Platinum 10 Ipilimumab 10 1,2-diaminocyclohexaneplatinum II citrate 10 atezolizumab 9 Drug Therapy 9 Albumin-Bound Paclitaxel 9 tislelizumab 8 Surgical Procedures, Operative 7 Standard of Care 7 Chemoradiotherapy 7 Biopsy 7 130-nm albumin-bound paclitaxel 7 toripalimab 6 avelumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡